|
Volumn 31, Issue 3, 2008, Pages
|
The rosigliazone meta-analysis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ROSIGLITAZONE;
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ANTIDIABETIC AGENT;
DRUG MARKETING;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
HEART DEATH;
HEART INFARCTION;
LETTER;
RISK ASSESSMENT;
CHEMICALLY INDUCED DISORDER;
DEATH;
HEART MUSCLE ISCHEMIA;
HUMAN;
META ANALYSIS;
NON INSULIN DEPENDENT DIABETES MELLITUS;
RANDOMIZED CONTROLLED TRIAL;
DEATH;
DIABETES MELLITUS, TYPE 2;
HUMANS;
HYPOGLYCEMIC AGENTS;
META-ANALYSIS AS TOPIC;
MYOCARDIAL INFARCTION;
MYOCARDIAL ISCHEMIA;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
THIAZOLIDINEDIONES;
|
EID: 61449242756
PISSN: 01495992
EISSN: 19355548
Source Type: Journal
DOI: 10.2337/dc07-2147 Document Type: Letter |
Times cited : (3)
|
References (4)
|